Progentix Orthobiology (Netherlands) - Dec 2007

BioGeneration Ventures has invested in Progentix Orthobiology in exchange for a minority stake.

Company

Founded in 2007, Progentix Orthobiology BV develops a unique suite of osteoinductive material products for clinical application in bone regenerative surgery. Progentix bone graft material is based on surface structured ceramic biomaterial scaffolds that have the ability to attract growth factors and stems cells after implantation, which results in the induction of bone growth. These materials are not only superior to currently available synthetic ceramic bone grafts, but based on their bone healing and regeneration potential also directly compete with the gold standard of autologous bone, and the growth factors that are being used today and those under development. The new fund will support further technology validation and the generation of clinical proof of principle.

People

Edward van Wezel led the transaction for BioGeneration. The CEO remains unchanged. Edward Van Wezel and Dr Clemens van Blitterswijk, professor at the University of Twente, were appointed to the new board.

Advisers

Equity - Corp Advocaten, (Legal)

Sourced from: Benelux unquote" 56 (Jan 2008)

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Expansion
• Healthcare
• Netherlands